Atlas Trials

Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)

Clinical trial NCT04846829 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04846829
Sponsor
University of California, Los Angeles
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2017-04-24
Primary completion
2028-04-24
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.